Georg Hilfenhaus

853 total citations · 1 hit paper
17 papers, 545 citations indexed

About

Georg Hilfenhaus is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Georg Hilfenhaus has authored 17 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Georg Hilfenhaus's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Cells and Metastasis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Georg Hilfenhaus is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer Cells and Metastasis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Georg Hilfenhaus collaborates with scholars based in Germany, United States and United Kingdom. Georg Hilfenhaus's co-authors include Katharina Detjen, Bertram Wiedenmann, Christian Fischer, Ulrich Keilholz, Dieter Beule, Max Schmidt, Mani Nassir, Manuela Benary, Damian Rieke and Ulrich Keller and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Georg Hilfenhaus

13 papers receiving 540 citations

Hit Papers

Leveraging Large Language Models for Decision Support in ... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Hilfenhaus Germany 10 180 129 125 94 87 17 545
Tetsuhiro Kakimoto Japan 14 154 0.9× 82 0.6× 65 0.5× 133 1.4× 4 0.0× 23 602
Sisi Ma United States 12 216 1.2× 54 0.4× 40 0.3× 41 0.4× 9 0.1× 23 449
Hye Yoon Lee South Korea 18 124 0.7× 189 1.5× 91 0.7× 510 5.4× 9 0.1× 51 903
Bambang Widyantoro Indonesia 8 233 1.3× 40 0.3× 48 0.4× 99 1.1× 13 0.1× 36 636
Jiehua Li China 11 72 0.4× 44 0.3× 42 0.3× 99 1.1× 9 0.1× 43 359
Elon H. C. van Dijk Netherlands 25 411 2.3× 85 0.7× 29 0.2× 24 0.3× 32 0.4× 107 2.3k
Ping‐Ying Chang Taiwan 13 71 0.4× 23 0.2× 170 1.4× 103 1.1× 3 0.0× 51 499
Krishan Rasiah Australia 16 225 1.3× 29 0.2× 108 0.9× 156 1.7× 4 0.0× 31 1.0k
Mario Zanfardino Italy 9 138 0.8× 11 0.1× 77 0.6× 97 1.0× 11 0.1× 19 434
Xun Cao China 16 215 1.2× 24 0.2× 158 1.3× 135 1.4× 6 0.1× 45 505

Countries citing papers authored by Georg Hilfenhaus

Since Specialization
Citations

This map shows the geographic impact of Georg Hilfenhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Hilfenhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Hilfenhaus more than expected).

Fields of papers citing papers by Georg Hilfenhaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Hilfenhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Hilfenhaus. The network helps show where Georg Hilfenhaus may publish in the future.

Co-authorship network of co-authors of Georg Hilfenhaus

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Hilfenhaus. A scholar is included among the top collaborators of Georg Hilfenhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Hilfenhaus. Georg Hilfenhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Pelzer, Uwe, F Schneider, Anna Luisa Kühn, et al.. (2025). Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids. Cancer Cell International. 25(1). 321–321.
3.
Eich, Marie‐Lisa, Georg Hilfenhaus, Bernhard Ralla, et al.. (2024). Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer. Urology Case Reports. 57. 102879–102879.
4.
Hilfenhaus, Georg, Martina Welzel, Catarina Alisa Kunze, et al.. (2024). Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 153–153. 9 indexed citations
6.
Hasenburg, Annette, et al.. (2024). Recurrent Intracranial Ewing Sarcoma. Ochsner Journal. 24(3). 213–218.
7.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade. Cancers. 15(8). 2367–2367. 11 indexed citations
8.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade. Journal of Clinical Medicine. 12(11). 3656–3656. 5 indexed citations
9.
Benary, Manuela, Max Schmidt, Dominik Soll, et al.. (2023). Leveraging Large Language Models for Decision Support in Personalized Oncology. JAMA Network Open. 6(11). e2343689–e2343689. 139 indexed citations breakdown →
10.
Hilfenhaus, Georg, Ana Mompeón, Divya P. Prajapati, et al.. (2020). A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier. Cancer Research. 81(3). 619–633. 11 indexed citations
11.
Hilfenhaus, Georg, Divya P. Prajapati, Feiyang Ma, et al.. (2018). Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers. The Journal of Cell Biology. 217(8). 2813–2830. 25 indexed citations
12.
Ziyad, Safiyyah, Jesse D. Riordan, Trent Su, et al.. (2018). A Forward Genetic Screen Targeting the Endothelium Reveals a Regulatory Role for the Lipid Kinase Pi4ka in Myelo- and Erythropoiesis. Cell Reports. 22(5). 1211–1224. 14 indexed citations
13.
Detjen, Katharina, Georg Hilfenhaus, Martina Welzel, et al.. (2014). Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer. Cancer Research. 74(5). 1529–1540. 94 indexed citations
14.
Hilfenhaus, Georg, Ulrich‐Frank Pape, Henning Jann, et al.. (2013). Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients. Endocrine Related Cancer. 20(3). 305–319. 29 indexed citations
15.
Fischer, Christian, Ulrich‐Frank Pape, Katharina Detjen, et al.. (2012). Prognostic relevance of circulating PIGF levels in patients with neuroendocrine tumors.. Journal of Clinical Oncology. 30(15_suppl). 4128–4128. 3 indexed citations
16.
Schulz, Petra, Christian Fischer, Katharina Detjen, et al.. (2011). Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancer. The FASEB Journal. 25(10). 3325–3335. 58 indexed citations
17.
Fiebeler, Anette, Jürg Nussberger, Erdenechimeg Shagdarsuren, et al.. (2005). Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage. Circulation. 111(23). 3087–3094. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026